These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34922740)

  • 1. Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription.
    Maillard M; Louveau B; Vilquin P; Goldwirt L; Thomas F; Mourah S
    Therapie; 2022; 77(2):171-183. PubMed ID: 34922740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics: Driving Personalized Medicine.
    Sadee W; Wang D; Hartmann K; Toland AE
    Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review.
    Vaidhya A; Ghildiyal K; Rajawat D; Nayak SS; Parida S; Panigrahi M
    Anim Genet; 2024 Feb; 55(1):3-19. PubMed ID: 37990577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genome sequencing and personalized medicine: perspectives and limitations].
    Le Gall JY; Debré P;
    Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
    Tavakolpour S; Darvishi M; Ghasemiadl M
    Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer genomics guide clinical practice in personalized medicine.
    Lehmann-Che J; Poirot B; Boyer JC; Evrard A
    Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products.
    Zhou Y; Peng S; Wang H; Cai X; Wang Q
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel precision medicine approaches and treatment strategies in hematological malignancies.
    Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
    J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection.
    Kou T; Kanai M; Kamada M; Nakatsui M; Matsumoto S; Okuno Y; Muto M
    Methods Mol Biol; 2018; 1825():413-424. PubMed ID: 30334215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Implementing Pharmacogenomics Study in Cancer.
    Romero Lagunes ML; Vera Badillo FE
    Adv Exp Med Biol; 2019; 1168():43-77. PubMed ID: 31713164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics: from bedside to clinical practice.
    Marsh S; McLeod HL
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.